55 studies found for:    "Dermatofibroma"
Show Display Options
Rank Status Study
21 Active, not recruiting Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma
Conditions: Adult Angiosarcoma;   Adult Desmoplastic Small Round Cell Tumor;   Adult Epithelioid Sarcoma;   Adult Extraskeletal Chondrosarcoma;   Adult Extraskeletal Osteosarcoma;   Adult Fibrosarcoma;   Adult Leiomyosarcoma;   Adult Liposarcoma;   Adult Malignant Fibrous Histiocytoma of Bone;   Adult Malignant Hemangiopericytoma;   Adult Malignant Mesenchymoma;   Adult Neurofibrosarcoma;   Adult Rhabdomyosarcoma;   Adult Synovial Sarcoma;   Childhood Angiosarcoma;   Childhood Desmoplastic Small Round Cell Tumor;   Childhood Epithelioid Sarcoma;   Childhood Fibrosarcoma;   Childhood Leiomyosarcoma;   Childhood Liposarcoma;   Childhood Malignant Hemangiopericytoma;   Childhood Malignant Mesenchymoma;   Childhood Neurofibrosarcoma;   Childhood Synovial Sarcoma;   Dermatofibrosarcoma Protuberans;   Metastatic Childhood Soft Tissue Sarcoma;   Mixed Childhood Rhabdomyosarcoma;   Pleomorphic Childhood Rhabdomyosarcoma;   Previously Treated Childhood Rhabdomyosarcoma;   Previously Untreated Childhood Rhabdomyosarcoma;   Recurrent Adult Soft Tissue Sarcoma;   Recurrent Childhood Rhabdomyosarcoma;   Recurrent Childhood Soft Tissue Sarcoma;   Stage III Adult Soft Tissue Sarcoma;   Stage IV Adult Soft Tissue Sarcoma
Interventions: Biological: cixutumumab;   Drug: doxorubicin hydrochloride;   Other: laboratory biomarker analysis
22 Active, not recruiting A Study of Bevacizumab in Combination With Chemotherapy for Treatment of Osteosarcoma
Conditions: Osteosarcoma;   Malignant Fibrous Histiocytoma (MFH) of Bone
Interventions: Biological: Bevacizumab;   Drug: Chemotherapy (Cisplatin, Doxorubicin, Methotrexate, Ifosfamide, Etoposide)
23 Unknown  Bevacizumab and Radiation Therapy for Sarcomas
Conditions: Soft Tissue Sarcoma;   Fibrous Histiocytoma;   Liposarcoma;   Leiomyosarcoma;   Fibrosarcoma;   Synovial Sarcoma
Interventions: Drug: Bevacizumab;   Procedure: Radiation Therapy
24 Recruiting Gemcitabine and Docetaxel in Combination With Pazopanib (Gem/Doce/Pzb) for the Neoadjuvant Treatment of Soft Tissue Sarcoma (STS)
Conditions: Sarcoma;   Leiomyosarcoma;   Malignant Peripheral Nerve Sheath Tumor;   Malignant Fibrous;   Histiocytoma/Undifferentiated Pleomorphic Sarcoma
Intervention: Drug: Gemcitabine and Docetaxel in Combination with Pazopanib
25 Active, not recruiting Gemcitabine and Docetaxel With Bevacizumab in Selected Sarcoma Subtypes
Conditions: Sarcoma;   Leiomyosarcoma;   Malignant Fibrous;   Histiocytoma;   Angiosarcoma
Intervention: Drug: gemcitabine and docetaxel with bevacizumab
26 Recruiting To Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors
Conditions: Neuroblastoma;;   Rhabdomyosarcoma;;   Ewing's Sarcoma;;   Ewing's Tumor;;   Sarcoma, Ewing's;;   Sarcomas, Epitheliod;;   Sarcoma, Soft Tissue;;   Sarcoma, Spindle Cell;;   Melanoma;;   Malignant Melanoma;;   Clinical Oncology;;   Oncology, Medical;;   Pediatrics, Osteosarcoma;;   Osteogenic Sarcoma;;   Osteosarcoma Tumor;;   Sarcoma, Osteogenic;;   Tumors;;   Cancer;;   Neoplasia;;   Neoplasm;;   Histiocytoma;;   Fibrosarcoma;;   Dermatofibrosarcoma
Intervention: Drug: nab-paclitaxel
27 Recruiting Autologous Dendritic Cell Vaccine Loaded With Allogeneic Tumor Lysate Expression of Cancer Testis Antigens in Patients With Soft Tissue Sarcoma
Conditions: Sarcoma;   Neoplasms, Connective and Soft Tissue
Intervention: Biological: Autologous dendritic cell vaccine
28 Completed Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors
Condition: Tumor
Interventions: Drug: belinostat;   Drug: 5-Fluorouracil (5-FU)
29 Unknown  External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases
Condition: Cancer
Interventions: Drug: indinavir sulfate;   Drug: ritonavir;   Radiation: radiation therapy
30 Completed PET Scan Combined With CT Scan in Predicting Response in Patients Undergoing Chemotherapy and Surgery for Soft Tissue Sarcoma
Condition: Sarcoma
Interventions: Biological: pegfilgrastim;   Drug: doxorubicin hydrochloride;   Drug: ifosfamide;   Drug: pegylated liposomal doxorubicin hydrochloride;   Procedure: conventional surgery;   Radiation: fludeoxyglucose F 18
31 Completed Safety and Efficacy Study of Torisel and Liposomal Doxorubicin for Patients With Recurrent Sarcoma
Condition: Sarcoma
Intervention: Drug: temsirolimus (Torisel) plus liposomal doxorubicin (Doxil)
32 Unknown  Tissue Sample Collection From Patients With Soft Tissue Sarcoma of the Arms, Hands, Legs, or Feet Treated on Clinial Trial CRUK-VORTEX
Condition: Sarcoma
Interventions: Genetic: microarray analysis;   Genetic: molecular diagnostic method;   Other: biologic sample preservation procedure
33 Completed Ifosfamide or Doxorubicin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma
Condition: Sarcoma
Interventions: Drug: doxorubicin hydrochloride;   Drug: ifosfamide
34 Unknown  Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma
Conditions: Endometrial Cancer;   Ovarian Cancer;   Sarcoma
Intervention: Drug: temozolomide
35 Completed Radiation Therapy in Treating Patients Who Have Undergone Surgery for Soft Tissue Sarcoma of the Arms, Hands, Legs, or Feet
Condition: Sarcoma
Interventions: Procedure: adjuvant therapy;   Radiation: radiation therapy
36 Recruiting Surgery With or Without Radiation Therapy in Treating Patients With Previously Untreated Nonmetastatic Retroperitoneal Soft Tissue Sarcoma
Condition: Sarcoma
Interventions: Procedure: therapeutic conventional surgery;   Radiation: 3-dimensional conformal radiation therapy
37 Completed Soblidotin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma
Condition: Sarcoma
Intervention: Drug: soblidotin
38 Completed Exatecan Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma
Condition: Sarcoma
Intervention: Drug: exatecan mesylate
39 Completed Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma
Conditions: Brain and Central Nervous System Tumors;   Endometrial Cancer;   Gastrointestinal Stromal Tumor;   Ovarian Cancer;   Sarcoma;   Small Intestine Cancer
Intervention: Drug: trabectedin
40 Unknown  Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma
Conditions: Endometrial Cancer;   Kidney Cancer;   Ovarian Cancer;   Pheochromocytoma;   Sarcoma
Interventions: Biological: filgrastim;   Drug: doxorubicin hydrochloride;   Drug: ifosfamide;   Drug: isolated perfusion;   Procedure: adjuvant therapy;   Procedure: conventional surgery;   Radiation: radiation therapy

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-55) Show next page of results
Indicates status has not been verified in more than two years